0001209191-23-037517.txt : 20230615
0001209191-23-037517.hdr.sgml : 20230615
20230615180644
ACCESSION NUMBER: 0001209191-23-037517
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brady Stephen R
CENTRAL INDEX KEY: 0001606241
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38935
FILM NUMBER: 231018800
MAIL ADDRESS:
STREET 1: C/O IMMUNE DESIGN CORP.
STREET 2: 1616 EASTLAKE AVE. E, SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atreca, Inc.
CENTRAL INDEX KEY: 0001532346
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273723255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-595-2595
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-13
0
0001532346
Atreca, Inc.
BCEL
0001606241
Brady Stephen R
C/O ATRECA, INC., 835 INDUSTRIAL RD.
SUITE 400
SAN CARLOS
CA
94070
1
0
0
0
0
Stock Option (right to buy)
1.18
2023-06-13
4
A
0
12000
0.00
A
2023-06-12
Class A Common Stock
12000
12000
D
The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date. All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control.
/s/ Herbert Cross, attorney-in-fact
2023-06-15